GH · Guardant Health, Inc.
$157.58
-5.60 (-3.43%)
At close · Aug 6
Market Cap
$21.15B
Shares
134.20M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-08-01 | $400,000,000 | — | — | — | 10-Q , filed 2026-07-30 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-06-30 YTD | $0 | 10-Q, filed 2026-07-30 |
| 2025-12-31 | $45,010,000 | 10-K, filed 2026-02-19 |
| 2024-12-31 | $0 | 10-K, filed 2026-02-19 |
| 2023-12-31 | $0 | 10-K, filed 2026-02-19 |
| 2020-12-31 | $0 | 10-K, filed 2021-02-25 |
| 2019-12-31 | $0 | 10-K, filed 2021-02-25 |
| 2018-12-31 | $172,000 | 10-K, filed 2021-02-25 |
| 2017-12-31 | $7,222,000 | 10-K, filed 2020-03-02 |
| 2016-12-31 | $100,000 | 10-K, filed 2019-03-19 |
Key facts
CIK
1576280
CUSIP
40131M109
13F (30d)
239 filings
214 filers
Visit website
Investor relations